What dose a GLP-1 monthly price buys
A monthly GLP-1 price looks like a price for your dose. On this roster it usually is not. 47 of the 61 sellers whose figure states what it buys publish a figure the seller states does not change with dose at all — a policy, not a per-dose price — and only 13 tie the figure to a stated dose. Behind them sit 56 further sellers whose monthly rate names no dose anywhere, which is why this site prints no figure for them.
Reviewed by Ellis Brandt. Sources checked September 2026.
What a monthly GLP-1 figure is a price of
591 GLP-1 sellers’ pages were read on September 2026. 117 publish at least one standing monthly rate. 61 of those also say, in their own words, what the figure buys — and it is only those 61 that can carry a price here at all, because a number with nothing attached to it is not a price a reader can use.
What those 61 sellers attach to the figure comes in three kinds, and the difference between them is not a detail. It decides whether the number will still be the number in three months, when the dose has gone up.
Share of the 61 sellers whose figure states what it buys. These three are exhaustive and exclusive: every published figure on this site is exactly one of them.
Read from each seller’s own public pages, September 2026. Counted over the 61 sellers whose figure states what it buys.
A flat-price policy is a real and useful thing for a seller to publish, and 46 of the 61 sellers whose figure states what it buys publish nothing but flat prices across every figure they list. But it answers a different question from the one a reader searching for a price by dose is asking. It says the figure will not rise when the dose does. It does not say what the figure buys at any particular dose, and it cannot be compared with a seller who priced one rung of a ladder — those are two different measurements, and dividing one by the other produces a number that describes neither.
That is why every board on this site carries a “what the figure buys” column rather than a bare price, and why the tirzepatide premium compares only the sellers who publish the same kind of number on both sides.
The sellers who name a dose, and what each one means by it
13 of the 61 sellers whose figure states what it buys tie their published figure to a stated dose. No two of them describe the same thing. Each is a true statement about what that seller sells. None of them is a statement about the same thing as any other, which is what makes “the price at 2.5 mg” a question this roster cannot answer even for the sellers who do name a dose.
All of them are printed below in full, each with the seller’s own words beside the figure. They are not summarized here: a summary would be a fourteenth description that no seller wrote.
The count is of distinct descriptions, compared word for word. Two sellers could describe the same dose in different words and be counted twice; two who describe it identically are only ever counted once.
The 13, in name order
Ordered by name, never by price. Nothing on this page is ranked, and this site publishes no ordering of sellers at all while its rubric is unsigned.
- BioGlow Health
$129 per month for semaglutide — 1 mg per month. Read September 2026.
The seller’s own words beside the figure:
1mg per month — $129.0
This is the lowest tier of the injectable semaglutide plan, with about one month's supply. Higher-dose tiers cost more. The medication is compounded and is not FDA-approved.
- Blis MD
$109.00 per month for semaglutide — 1 mg vial (0.5 mg/ml, 1 ml) = one month's supply dosed .25 mg per week. Read September 2026.
The seller’s own words beside the figure:
1 mg / 0.5mg /ml (1ml vial) (1 mth supply - .25 mg p/wk)$109.00
The starter dose is 0.25 mg weekly, with a one-month supply. Higher-dose options cost more. The listed price is available as a one-time purchase or subscription.
- CLYR Health
$130 per month for semaglutide — 0.4 mg per week (8 units), the lowest maintenance rung. Read September 2026.
The seller’s own words beside the figure:
MAINTAINING · 8 UNITS/WEEK (0.4MG) 8-Week cycle BEST VALUE 2 vials, one box · $259 billed once $130/mo
The charge is $259 every eight weeks; $130/month is the provider's monthly equivalent. This tier covers 0.4 mg weekly.
- Coby Health
$189 per month for semaglutide — a 12-week titration ladder running 1mg → 1.7mg → 2.4mg (three doses, not one). Read September 2026.
The seller’s own words beside the figure:
1mg > 1.7mg > 2.4mg: $189/mo ($597)
The charge is $597 for a three-month bundle, shipped together. The monthly figure is an equivalent, not a monthly bill. The titration plan starts at 1 mg.
- June Health
$209 per month for semaglutide — 2 mg semaglutide per tablet (with 10 mg pyridoxine), 30 tablets — the concentration the seller prices at this figure. Read September 2026.
The seller’s own words beside the figure:
2 mg / 10 mg (30 tabs) $209 per month
This is the second dose tier. The lower 1 mg tier is advertised at $187/month.
- Nova
$25 per month for semaglutide — 36 mcg — the 28-count monthly pack of the oral daily dose. Read September 2026.
The seller’s own words beside the figure:
Medication is **$25 monthly** (28-count of 36 mcg)
$25 covers medication only: 28 oral tablets at 36 mcg daily. A separate $99/month membership is required. The provider advertises a different combined rate of $116/month on its 90-day tier.
- Precision Telemed
$139.99 per month for semaglutide — 0.25 mg — the lowest dose only; the seller sells this plan as a single-dose maintenance program. Read September 2026.
The seller’s own words beside the figure:
MAINTENANCE PROGRAM Semaglutide Lowest dose only — flat monthly rate $139.99 /month flat rate every month — cancel anytime Lowest dose only (0.25 mg)
This rate is limited to the 0.25 mg maintenance program. The full program for patients increasing their dose costs $149.99.
- Primary Clinic (Direct GLP)
$108 per month for semaglutide — 1 mg to 1.25 mg — the semaglutide flex-dosing tier this price is printed against. Read September 2026.
The seller’s own words beside the figure:
1mg-1.25mg $108/month
This semaglutide tier covers 1–1.25 mg. Pricing is available only to active Primary Clinic DPC members; the $89/month membership is additional.
- Recovery Delivered
$219.99 per month for tirzepatide — 2.5 mg/week — the starting dose. Read September 2026.
The seller’s own words beside the figure:
Medication (price listed is for starting dose of 2.5mg/week)
This is the starting-dose tier, at $219.99. Higher-dose tiers cost more. Quarterly discounts are mentioned without a stated price.
- Rehydra+ Wellness
$119 per month for semaglutide — 0.25 mg and 0.5 mg only — the two doses this membership tier covers. Read September 2026.
The seller’s own words beside the figure:
Tier 1 $119/ month Normal Price: $199/Month – Includes Doses of 0.25mg and 0.5mg
This tier covers only 0.25 mg and 0.5 mg semaglutide and requires a six-month, non-cancelable commitment. The $199/month comparison is the regular price, not an added charge.
- RxPepsDirect
$108.64 per month for semaglutide — 11.2 mg vial at 5.6 mg/mL delivering 2.80 mg per week — the Month 6+ maintenance rung. Read September 2026.
The seller’s own words beside the figure:
Month 6+ · 11.2mg 5.6mg/mL · 2.80mg/wk $108.64
$108.64 covers an 11.2 mg semaglutide/B12 vial for a month at 2.80 mg weekly. A $39 medical visit and $15 shipping are additional. Medication is paid directly to the pharmacy.
- WeightCare
$199 per month for semaglutide — 0.25-1 mg per week. Read September 2026.
The seller’s own words beside the figure:
0.25-1 mg per week
This microdose plan is billed monthly but requires a three-month commitment. The month-to-month option costs $249/month.
- Wholesome Clinic
$249 per month for tirzepatide — 2 mg daily (oral dissolving tablet). Read September 2026.
The seller’s own words beside the figure:
Starter: 2 mg daily — $249/month
This is the lowest oral tirzepatide ODT tier, at 2 mg daily. Higher-dose tiers cost up to $349.
And one seller prices a concentration, which is not a dose
A strength — milligrams per milliliter, or per tablet — says how concentrated the medicine is. How much of it a patient takes in a week is a separate fact, and this seller does not state it beside the figure. It is kept out of the per-dose count above rather than rounded into it.
- EdgeRx
$199 per month for semaglutide — the 5 mg/mL 1-month supply named in the product line this price is printed on — a CONCENTRATION, not a weekly dose. Read September 2026.
The seller’s own words beside the figure:
Semaglutide 5 mg/mL with glycine + B12 · 1-month supply
The semaglutide program is listed as unavailable for purchase. This is an advertised waitlist price.
The sellers whose figure names no dose at all
56 of the 117 sellers who publish a standing monthly rate publish no figure that says what dose it buys. They are not sellers with no price; every one of them advertises a monthly number. Between them they publish 150 such figures, and this site prints none of them, because a monthly number with no stated dose behind it cannot be compared with any other number on any board here.
The seller tied no dose to the figure at all
122 of 150 — no dose is stated anywhere against the number
A dose sits near the figure and the seller never ties the two together
28 of 150 — co-occurrence is not assignment
Read from each seller’s own public pages, September 2026. Counted over the 150 monthly prices published by the 56 sellers whose every figure lacks a stated dose.
The second row is the one worth reading twice. On 28 figures a dose sits on the page near the price and the seller never says the one buys the other. Those are not treated as a pair here, and that costs this site rows it could otherwise print. The number would be real and the dose would be real, and the link between them would be ours — which is exactly the kind of claim a reader cannot check against the seller’s page.
Across every seller read, 38 figures fall that way. Each of the 56 sellers has its own count, and the reason for each one, on its own page under every seller we have read.
What this does not tell you
- Which dose you will end up on. That is a prescriber’s decision and nothing on this page is medical advice. What the four FDA-approved labels state about starting doses and escalation is on GLP-1 dose escalation schedules, which names no seller.
- What a flat-price seller charges at your dose. The answer is the same figure — that is what the policy says — but a policy is a statement about billing and not a promise about supply, and 55 of the 61 sellers whose figure states what it buys do not print the dose schedule their patients follow at all.
- Whether any of these figures is a good price. No company on this page is ranked, graded or recommended, no two amounts here are put on one axis, and this site names no cheapest seller. What each one publishes about its own price, pharmacy and cancellation terms is on its own page.
- Whether the figure is still the figure. Every price on this page carries the date it was read, and they were read on September 2026. Prices can change; confirm current terms with the provider before paying.
What none of these sellers publishes is counted on what sellers do not publish; where the same records are compared across two molecules, see the tirzepatide premium. No link on this page is paid.
The other findings
Each one says how many sellers it counted, and the counts differ on purpose: a question can only be asked of the sellers who published enough to answer it.
- How many sellers publish a price
What happened when the pages of every GLP-1 seller we could find were opened and read: how many published a figure at all, and how many published one that can be compared.
Counted over 588 sellers whose pages were opened.
- What drug the price is for
Whether a published GLP-1 figure says which drug it prices, and how often the number sits on a page that never names one.
Counted over 3018 published figures across 408 sellers.
- Compounded or branded
How often a seller says, beside the figure, whether the drug is compounded or the FDA-approved product — and the one case where it almost always does.
Counted over 3018 published figures across 408 sellers.
- What sellers do not publish
The pharmacy, the product class, the dose schedule and the cancellation terms: four things a reader needs before buying, and how many sellers publish each one.
Counted over 61 sellers whose figure states what it buys.
- The tirzepatide premium
What the same seller charges for tirzepatide against semaglutide — and why most sellers who sell both do not publish a pair a reader can put side by side.
Counted over 46 sellers publishing a figure for both molecules.
The boards
One board per buying decision, each the same table with the columns that decision needs.
- Semaglutide providers55 listed
Compare semaglutide plans, pharmacy details and cancellation terms.
- Tirzepatide providers52 listed
Compare tirzepatide plans, pharmacy details and cancellation terms.
- Providers that publish a price before the intake60 listed
See providers that show medication prices before the intake.
- GLP-1 providers with a published price, compared60 listed
Compare advertised prices, plan commitments and what’s included.
- GLP-1 providers for readers paying cash53 listed
Compare plans whose published price includes medication.
- GLP-1 telehealth providers61 listed
Compare GLP-1 prescribers, pharmacy details, care and cancellation terms.
Every board above was read September 2026 and carries its own dated, counted title.
What the labels say
The education pages read the FDA-approved prescribing information and name no seller.
- First-year GLP-1 costsresearch guide
A low monthly headline does not tell you what a year of treatment will cost. Compare the same medication and service package, then separate the total you expect to spend from the amount you must pay before treatment begins.
- Cancellation and refundsresearch guide
Canceling future membership charges, stopping an upcoming medication order and requesting a refund are three different requests. Get a written answer for each one that applies to you.
- Insurance denial documentsresearch guide
The next step depends on why coverage was denied. A missing document, a formulary restriction and an excluded benefit are different problems. Start with the written decision before paying someone to submit another request.
- Savings and cash-pay eligibilityresearch guide
A manufacturer savings card and a self-pay offer can have different eligibility rules, even for the same medicine. Match the offer to your coverage and exact product before using its advertised price in your budget.
- Verify your GLP-1 pharmacyresearch guide
The website taking your payment, the clinician prescribing and the pharmacy dispensing may be different businesses. Identify each one. A recognizable brand or a reassuring badge does not tell you who will fill the prescription.
- Changing GLP-1 providersresearch guide
Before ending your current service, establish what the new practice needs, what it will charge and when it can evaluate you. Transferring your records does not guarantee that another clinician will continue the same prescription.
- Weight regain after stoppingresearch guide
Weight regain occurred after treatment withdrawal in studies of semaglutide and tirzepatide. The findings support planning follow-up and affordability before an interruption, but they do not predict exactly what will happen to one person.
- Semaglutide vs tirzepatideresearch guide
What the four FDA-approved labels say each molecule is, what each is approved to treat, and where the two differ.
- How they workresearch guide
The receptor each molecule switches on, what the labels say that does to appetite, blood sugar and the stomach, and why one dose lasts a week.
- Is Ozempic insulin?research guide
What the Ozempic label calls semaglutide, how that differs from insulin, and where insulin appears on these labels as a separate medicine.
- Zepbound vs Ozempicresearch guide
Four brand names, two molecules and two kinds of approval: which of these products are the same drug, and what each one is actually approved to do.
- Dose escalation schedulesresearch guide
The starting dose, the escalation interval and the maximum dose each label sets, and why they are not interchangeable.
- Side effect ratesresearch guide
What each label reports for nausea, vomiting, diarrhea and constipation — and the sentence every label prints above those numbers.
- Hair lossresearch guide
Which labels report hair loss, the rate against placebo where a trial measured it, and why two of them put no number on it.
- Fatigue and tirednessresearch guide
Which labels list fatigue, the rate against placebo where a trial measured it, and what each label counts as fatigue.
- Missed dose rulesresearch guide
The window each label gives for a late dose, and the minimum gap it requires when the injection day changes.
- Drug interactionsresearch guide
Insulin and sulfonylureas, oral medications, and the oral-contraceptive precaution that appears on two of these four labels and not the other two.
- Buying one onlineresearch guide
The agency's own warning signs for a telehealth GLP-1 seller, its 28-day vial rule, and what it says about drugs that arrive warm.
- Zepbound by doseresearch guide
What each Zepbound dose achieved in the trials printed in its label, what the label says about choosing a maintenance dose, and what the higher doses cost in side effects.
- Zepbound at 3 monthsresearch guide
What does the Zepbound label report about three-month weight loss and maintenance dosing?
- Injecting tirzepatideresearch guide
The injection sites, the rotation rule and the steps for the single-dose pen, the KwikPen and the vial and syringe, exactly as the FDA-approved Instructions for Use give them.
- Refrigeration and storageresearch guide
How cold each pen is kept, how many days it can spend at room temperature, and what the labels say about heat and freezing.
- Who should not take oneresearch guide
The boxed warning every one of these labels carries, the two contraindications, and which warnings appear on which product.